TY - GEN
T1 - Deviations in the endocrine system and brain of patients with fibromyalgia
T2 - Cause or consequence of pain and associated features: Annals of the New York Academy of Sciences
AU - Geenen, Rinie
AU - Bijlsma, Johannes W. J.
PY - 2010
Y1 - 2010
N2 - The brain and endocrine system are crucial interfaces responding to pathological and psychological processes. This review discusses whether endocrine deviations and structural and functional changes in the brain are a cause or consequence of fibromyalgia. Studies in patients with fibromyalgia virtually uniformly observed subtle alterations in hypothalamic pituitary adrenal functioning, hyporeactive autonomic nervous system responsiveness to stressors, and structural and functional changes in the brain. Our model proposes that predisposing factors, such as genetic vulnerability and trauma, have led to an alteration of the nociceptive system including several neuroendocrine changes. The resulting pain and associated symptoms, such as sleep disturbance, low fitness, fatigue, stress, and distress, are a cause of new neuroendocrine changes. The model predicts that favorable neuroendocrine changes are to be expected after successful pharmacological or non-pharmacological interventions that target pain and associated symptoms. © 2010 New York Academy of Sciences.
AB - The brain and endocrine system are crucial interfaces responding to pathological and psychological processes. This review discusses whether endocrine deviations and structural and functional changes in the brain are a cause or consequence of fibromyalgia. Studies in patients with fibromyalgia virtually uniformly observed subtle alterations in hypothalamic pituitary adrenal functioning, hyporeactive autonomic nervous system responsiveness to stressors, and structural and functional changes in the brain. Our model proposes that predisposing factors, such as genetic vulnerability and trauma, have led to an alteration of the nociceptive system including several neuroendocrine changes. The resulting pain and associated symptoms, such as sleep disturbance, low fitness, fatigue, stress, and distress, are a cause of new neuroendocrine changes. The model predicts that favorable neuroendocrine changes are to be expected after successful pharmacological or non-pharmacological interventions that target pain and associated symptoms. © 2010 New York Academy of Sciences.
UR - https://www.scopus.com/pages/publications/77951210050
U2 - 10.1111/j.1749-6632.2009.05290.x
DO - 10.1111/j.1749-6632.2009.05290.x
M3 - Conference contribution
SN - 9781573317696
VL - 1193
T3 - Annals of the New York Academy of Sciences
SP - 98
EP - 110
BT - Neuroendocrine Immunology in Rheumatic Diseases: Translation from Basics to Clinics
PB - Blackwell Publishing Inc.
ER -